<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-29T20:44:25Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/11211" metadataPrefix="marc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/11211</identifier><datestamp>2026-02-05T08:20:00Z</datestamp><setSpec>com_10259_11209</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_11210</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Ramos-Hernández, Rafael</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Miguel Ortega, Alvaro</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Martínez Ferrán, María</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Fernández-Lázaro, Diego</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Busto Vázquez, Natalia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Mielgo Ayuso, Juan</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2025-10</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Sarcopenia is a major contributor to frailty and functional decline among older adults. Combining exercise with nutritional strategies such as creatine monohydrate (CRE) and β-hydroxy-β-methylbutyrate (HMB) supplementation may help to preserve strength and independence. To evaluate the effects of 6-week CRE + HMB supplementation combined with an integral physical conditioning (IPC) program on functional strength and body composition in physically active older adults. In a randomized, double-blind, placebo-controlled crossover trial, 30 older adults (20 men, 10 women; ≥ 60 years) completed two 6-week intervention periods (CRE + HMB or placebo) separated by a 3-week washout. The IPC program performed in both conditions consisted of four supervised weekly sessions combining strength, power, multicomponent circuits, high-intensity interval and moderate intensity continuous training), performed at 40–100% training heart rate (THR) and 20–90% one-repetition maximum (1RM) and structured as warm-up, main part and cooldown. Functional strength and body composition (bioelectrical impedance analysis) were assessed pre- and post-intervention, respectively. Significant time × group interactions were observed for fat mass, fat-free mass, total muscle mass, skeletal muscle mass, appendicular skeletal muscle mass, muscle mass index, skeletal muscle index and ALM/BMI (all p &lt; 0.05). The CRE + HMB group showed reductions in fat mass and body fat percentage, with slight numerical increases in muscle parameters, whereas the placebo group exhibited opposite trends. However, within-group changes were not statistically significant. In contrast, CRE + HMB significantly improved multiple functional strength outcomes, including leg/back strength, arm flexion strength, upper-body endurance (dumbbell flexion, push-ups, isometric hold) and core endurance (crunches). Regression analyses suggested that these improvements were largely independent of changes in muscle mass, supporting a potential neuromuscular mechanism. Six weeks of CRE + HMB supplementation combined with IPC enhanced functional strength and endurance in active older adults, largely independent of changes in muscle mass. This combined approach represents a promising strategy for preserving functional capacity and promoting healthy ageing.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">2509-2715</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">https://hdl.handle.net/10259/11211</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.1007/s11357-025-01889-y</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">2509-2723</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Creatine monohydrate</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">β-Hydroxy-βmethylbutyrate</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Functional strength</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Sarcopenia</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Older adults</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Multicomponent exercise</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Muscle quality</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Neuromuscular adaptations</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Healthy aging</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Body composition</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Combined creatine and HMB co-supplementation improves functional strength independent of muscle mass in physically active older adults: a randomized crossover trial</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>